On January 30, 2023, Apexigen, Inc. closed the transaction. The company issued 1,995,708 common shares at an issue price of $1.4 per share for aggregate gross proceeds of approximately $2,793,991.2. The transaction included participation from 13 investors. The company paid finder's fee of $45,000 for the transaction.